TDM for Optimized Outcome in Patients With mRCC.

Clinical trial NCT04659343 · RECRUITING

Trial details

NCT number: NCT04659343
Sponsor: Niels Fristrup
Status: RECRUITING
Study type: OBSERVATIONAL

Kidney Cancer Renal Cell Carcinoma Metastatic Drug Toxicity Drug Side Effect Drug Mechanism

Start date: 2020-11-01
Primary completion: 2028-08-31
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.